Cargando…

Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer

Gastric cancer is one of the most common malignancies worldwide. However, genetic alterations leading to this disease are largely unknown. Gene amplification is one of the most frequent genetic alterations, which is believed to play a major role in the development and progression of gastric cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jing, Yao, Demao, Liu, Wei, Wang, Na, Lv, Hongjun, He, Nongyue, Shi, Bingyin, Hou, Peng, Ji, Meiju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344242/ https://www.ncbi.nlm.nih.gov/pubmed/22606006 http://dx.doi.org/10.3390/ijms13044714

Ejemplares similares

Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
por: Shi, Jing, et al.
Publicado: (2012)

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2016)

Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer
por: Shi, Jing, et al.
Publicado: (2015)

Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Metallothionein 1G functions as a tumor suppressor in thyroid cancer through modulating the PI3K/Akt signaling pathway
por: Fu, Jiao, et al.
Publicado: (2013)

Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinoma
por: Li, Heng, et al.
Publicado: (2018)

Increased expression of NAF1 contributes to malignant phenotypes of glioma cells through promoting protein synthesis and associates with poor patient survival
por: Wei, Jing, et al.
Publicado: (2019)

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
por: Gao, Ke, et al.
Publicado: (2015)

Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients
por: Dang, Siwen, et al.
Publicado: (2014)

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients
por: Chen, Lihong, et al.
Publicado: (2016)

Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
por: Ji, Meiju, et al.
Publicado: (2011)

Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter
por: Zhang, Lihong, et al.
Publicado: (2011)

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
por: Liu, Rui, et al.
Publicado: (2017)

Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients
por: Zhang, Guanjun, et al.
Publicado: (2013)

Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice
por: Yang, Fei, et al.
Publicado: (2021)

c-Myc is Required for BRAF(V600E)-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
por: Qu, Yiping, et al.
Publicado: (2017)

Chromosome 8q as the most frequent target for amplification in early gastric carcinoma
por: KANG, JI UN
Publicado: (2014)

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAF(V600E)-driven human cancers
por: Wu, Yongxing, et al.
Publicado: (2021)

Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas
por: Akama, Yoshihiko, et al.
Publicado: (1995)

Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway
por: Wang, Liping, et al.
Publicado: (2015)

PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer
por: Liu, Wei, et al.
Publicado: (2016)

Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3
por: Lv, Yanyan, et al.
Publicado: (2016)

HACE1-mediated NRF2 activation causes enhanced malignant phenotypes and decreased radiosensitivity of glioma cells
por: Da, Chenxing, et al.
Publicado: (2021)

Upregulation of FGD6 Predicts Poor Prognosis in Gastric Cancer
por: Zeng, Jianmin, et al.
Publicado: (2021)

Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing
por: Li, Mengdan, et al.
Publicado: (2017)

CYP2S1 is a synthetic lethal target in BRAF(V600E)-driven thyroid cancers
por: Li, Yiqi, et al.
Publicado: (2020)

Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms
por: Su, Xi, et al.
Publicado: (2019)

ALK gene amplification is associated with poor prognosis in colorectal carcinoma
por: Bavi, P, et al.
Publicado: (2013)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Wang, Dan-dan, et al.
Publicado: (2012)

Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
por: Su, Xi, et al.
Publicado: (2020)

Low STYK1 expression indicates poor prognosis in gastric cancer
por: Fang, Jian, et al.
Publicado: (2018)

Recurrent Implantation Failure Is More Frequently Seen in Female Patients with Poor Prognosis
por: Ocal, Pelin, et al.
Publicado: (2012)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer
por: Xu, Peng, et al.
Publicado: (2021)

Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer
por: He, Jinsong, et al.
Publicado: (2022)

Stearoyl-CoA desaturase 1 (SCD1) facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer
por: Wang, Chao, et al.
Publicado: (2020)

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
por: He, Jun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_248dfnnatnckauv8hkhud3p355